Detalhe da pesquisa
1.
First-In-Human Phase I Study of Tinengotinib (TT-00420), a Multiple Kinase Inhibitor, as a Single Agent in Patients With Advanced Solid Tumors.
Oncologist
; 29(4): e514-e525, 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38297981
2.
Safety, tolerability, and clinical activity of selinexor in combination with pembrolizumab in treatment of metastatic non-small cell lung cancer.
Cancer
; 129(17): 2685-2693, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37129197
3.
Phase 1b study of combined selinexor and eribulin for the treatment of advanced solid tumors and triple-negative breast cancer.
Cancer
; 129(14): 2201-2213, 2023 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37016732
4.
A Phase I Trial of Bevacizumab and Temsirolimus in Combination With Valproic Acid in Advanced Solid Tumors.
Oncologist
; 28(12): 1100-e1292, 2023 Dec 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37311055
5.
A phase i study of ixazomib and erlotinib in patients with advanced solid tumors.
Invest New Drugs
; 40(1): 99-105, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34468905
6.
Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: Results of a single-center, multi-arm phase Ib study.
Invest New Drugs
; 40(2): 290-299, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34562230
7.
Supportive care for the prevention of nausea, vomiting and anorexia in a phase 1B study of selinexor in advanced cancer patients: an exploratory study.
Invest New Drugs
; 40(1): 124-133, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34559346
8.
Overview of Ocular Side Effects of Selinexor.
Oncologist
; 26(7): 619-623, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33728727
9.
Patient-Reported Out-of-Pocket Costs and Financial Toxicity During Early-Phase Oncology Clinical Trials.
Oncologist
; 26(7): 588-596, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33783054
10.
Pembrolizumab for advanced penile cancer: a case series from a phase II basket trial.
Invest New Drugs
; 39(5): 1405-1410, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33770291
11.
The clinical efficacy and safety of single-agent pembrolizumab in patients with recurrent granulosa cell tumors of the ovary: a case series from a phase II basket trial.
Invest New Drugs
; 39(3): 829-835, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33415580
12.
Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Invest New Drugs
; 39(5): 1357-1365, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33909232
13.
Phase II study of pembrolizumab efficacy and safety in women with recurrent small cell neuroendocrine carcinoma of the lower genital tract.
Gynecol Oncol
; 158(3): 570-575, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32534809
14.
Phase 1 study of the combination of vemurafenib, carboplatin, and paclitaxel in patients with BRAF-mutated melanoma and other advanced malignancies.
Cancer
; 125(3): 463-472, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30383888
15.
Cancer-Related Internet Use and Its Association With Patient Decision Making and Trust in Physicians Among Patients in an Early Drug Development Clinic: A Questionnaire-Based Cross-Sectional Observational Study.
J Med Internet Res
; 21(3): e10348, 2019 03 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-30869638
16.
Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials.
Br J Cancer
; 118(6): 763-769, 2018 03 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-29462132
17.
Comparative Effectiveness of an mTOR-Based Systemic Therapy Regimen in Advanced, Metaplastic and Nonmetaplastic Triple-Negative Breast Cancer.
Oncologist
; 23(11): 1300-1309, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30139837
18.
Correction to: Selinexor in combination with topotecan in patients with advanced or metastatic solid tumors: Results of an open-label, single-center, multi-arm phase Ib study.
Invest New Drugs
; 40(2): 461, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34705134
19.
Correction to: Selinexor in combination with carboplatin and paclitaxel in patients with advanced solid tumors: results of a singlecenter, multiarm phase Ib study.
Invest New Drugs
; 40(2): 463, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-34731355
20.
Evaluation of 122 advanced-stage cutaneous squamous cell carcinomas by comprehensive genomic profiling opens the door for new routes to targeted therapies.
Cancer
; 122(2): 249-57, 2016 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26479420